Quantcast

Latest Antibody Stories

2015-04-06 08:29:14

Adds Immuno-Oncology Development Strength to AnaptysBio's Product Pipeline SAN DIEGO, April 6, 2015 /PRNewswire/ -- AnaptysBio, Inc., a leader in the discovery and development of therapeutic

2015-04-01 08:30:54

TAMPA, Fla., April 1, 2015 /PRNewswire/ -- Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc.

2015-03-26 08:33:26

Scientists at acib develop world's first continuous purification method for valuable drugs.

2015-03-19 08:28:14

NORTH CHICAGO, Ill., March 19, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has entered into an exclusive worldwide license agreement with C(2)N Diagnostics, a privately

511326691
2015-03-16 11:40:28

One human antibody known as BI 655066 is a promising candidate to be used to target the inflammation-causing protein, interleukin-23.

2015-03-16 08:32:13

NantCell To Acquire Exclusive Rights to Antibodies Including CAR-TNK(TM) Products and the Checkpoint Inhibitors PD-1 and PD-L1 SAN DIEGO, Mar.

2015-03-12 23:04:00

The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014.

2015-03-12 12:29:58

DUBLIN, Mar.

2015-02-23 08:29:46

SAN DIEGO, Feb. 23, 2015 /PRNewswire/ -- Sorrento Therapeutics, Inc.

2015-02-23 04:21:01

OXFORD, England and SAN JOSE, California, February 23, 2015 /PRNewswire/ -- Oxford BioTherapeutics, an international biotechnology company focused on the development of


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related